Share on StockTwits

MYOS Corp (NASDAQ:MYOS) Director Peter Diamandis acquired 3,444 shares of MYOS Corp stock on the open market in a transaction dated Monday, August 18th. The shares were purchased at an average price of $14.51 per share, for a total transaction of $49,972.44. Following the completion of the purchase, the director now directly owns 5,444 shares in the company, valued at approximately $78,992. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of MYOS Corp (NASDAQ:MYOS) traded up 0.44% on Tuesday, hitting $13.81. The stock had a trading volume of 5,700 shares. MYOS Corp has a one year low of $6.00 and a one year high of $16.85. The stock has a 50-day moving average of $14.12 and a 200-day moving average of $12.11. The company’s market cap is $40.3 million.

MYOS Corp (NASDAQ:MYOS) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($0.34) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.20) by $0.14. The company had revenue of $1.68 million for the quarter.

A number of research firms have recently commented on MYOS. Analysts at Zacks reiterated an “outperform” rating on shares of MYOS Corp in a research note on Thursday, August 14th. They now have a $20.00 price target on the stock.

MYOS Corporation is engaged in the discovery, development and commercialization of therapeutic products, nutritional supplements and other technologies to improving the health and performance of muscle tissue.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.